NCT00508950

Brief Summary

The study will identify healthy adults who have been vaccinated against pneumococcus, and collect blood for the purpose of developing laboratory assays.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
152

participants targeted

Target at P75+ for not_applicable healthy

Timeline
Completed

Started Aug 2007

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2007

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 30, 2007

Completed
2 days until next milestone

Study Start

First participant enrolled

August 1, 2007

Completed
8.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

August 17, 2016

Status Verified

August 1, 2016

Enrollment Period

8.8 years

First QC Date

July 27, 2007

Last Update Submit

August 16, 2016

Conditions

Healthy

Keywords

VaccinesPneumococcal Conjugate VaccineAdult

Outcome Measures

Primary Outcomes (1)

  • To identify potential serum donors and obtain unit volumes of blood from these donors for use in pneumococcal opsonophagocytic assay development.

    8 years

Study Arms (1)

All subjects

OTHER

All subjects

Procedure: Large volume blood draw

Interventions

Large volume blood drawPROCEDURE

Large volume blood draw

All subjects

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adults 18-70 years of age
  • Must have received 23vPS pneumococcal vaccine

You may not qualify if:

  • Bleeding diathesis
  • Pregnancy
  • Chronic disease which could be worsened by donating blood
  • Receipt of blood, blood products or immune globulin within six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Frontage Clinical Services Inc.

Secaucus, New Jersey, 07094, United States

Location

Related Links

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2007

First Posted

July 30, 2007

Study Start

August 1, 2007

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

August 17, 2016

Record last verified: 2016-08

Locations

US(1)